Personality styles and adherence to treatment in adult patients with Multiple Sclerosis

Bustos, Karina; Navarra, Javier; Godoy, Melisa; González, Mariana

doi:10.1016/j.msard.2022.103699

Cited by 2 publications

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Because studies have reported that personality traits affect self-management strategies, disease adaptation and treatment in MS patients. 5,6 It has also been reported that neuroticism personality trait is more dominant in MS patients and is associated with anxiety and depressive mood. [7][8][9][10] Recent studies have shown that neuroticism is associated with impaired physical disability, cognitive functioning and mental resilience.…”

Section: Introductionmentioning

confidence: 99%

Relationship of personality traits with stigmatization, depression, and quality of life in patients with multiple sclerosis

Yeni,

Terzi

2023

NeuroAsia

View full text Add to dashboard Cite

Background & Objective: Personality traits are associated with mental health and quality of life in patients with multiple sclerosis (MS). The aim of this study was to determine personality traits in patients with MS and to examine the relationship between these traits and stigmatization, depression and quality of life. Method: This descriptive, cross-sectional study included 80 MS patients and 96 healthy controls. Data were collected online between June and July 2022. Patient/person information form, Eysenck Personality Questionnaire Revised-Short Form (EPQ-RS), Neuro Quality of Life-Stigma Scale, Beck Depression Inventory and MS Quality of Life Scale-54 were used for data collection. Results: When the age variable was controlled, it was found that the mean neuroticism subscale score was higher (p=0.003) and the mean extraversion subscale score was lower (p=0.018) than the control group. In addition, the mean extraversion score was found to be negatively correlated with stigmatization (p<0.05) and depression (p<0.01), and positively correlated with the physical sub-dimension of quality of life (p<0.01). Neuroticism and psychoticism sub-dimensions were positively correlated with stigmatization and depression and negatively correlated with all sub-dimensions of quality of life (p<0.01). In addition, regression analysis showed that depression significantly contributed to the physical health dimension of quality of life and neuroticism personality trait significantly contributed to the mental health dimension. Conclusions: Neurotic personality traits were found to be more dominant in patients with MS. Moreover, all sub-dimensions of personality traits were associated with stigmatization, depression and quality of life. Therefore, personality traits should be considered in interventions to improve mental health and quality of life.

show abstract

Section: Introductionmentioning

confidence: 99%

Relationship of personality traits with stigmatization, depression, and quality of life in patients with multiple sclerosis

Yeni,

Terzi

2023

NeuroAsia

View full text Add to dashboard Cite

show abstract

Multipl Skleroz Hastalarında Hastalık Modifiye Edici Tedavilere Uyumu Etkileyen Faktörlerin Değerlendirilmesi

Koç,

Sarıdaş,

Turan

2024

Uludağ Üniversitesi Tıp Fakültesi Dergisi

View full text Add to dashboard Cite

Multiple sclerosis is an acquired disabling neurological disease that affects approximately 2.3 million people worldwide, most commonly in young adults. Since MS is a chronic disease, patients need to use long-term treatment. Patients' compliance with treatment is an issue that should be taken into consideration as a priority since it affects the course of the disease and long-term prognosis. Many factors affect treatment compliance. Identifying and correcting adverse factors affects treatment efficacy, safety, and disease outcomes. In this study, we aimed to evaluate the factors affecting the compliance of patients followed in an MS clinic to disease-modifying treatments. 209 MS patients were included in the study, and their age, gender, disease durations, education level, income, medication usage, and the administered way were recorded. The Morisky Medication Adherence Scale-8 (MMAS-8) was applied to the patients with MS. The mean MMAS-8 score was 6.05±1.94. Treatment compliance was 31% low (n=66), 36.4% moderate (n=76), and 32.1% high (n=67). No difference was detected in terms of treatment compliance according to age, gender, disease duration, income level, disease-modifying treatments, and the type and administration way of these treatments (p= 0.074, 0.070, 0.600, 0.976, 0.940, 0.356, 0.249, 0.053, 0.701, respectively). In our study, age, education level, disease duration, treatment option, or route of administration did not affect compliance with disease-modifying treatment in MS patients. Our study results indicate that different factors affecting medication adherence in MS patients need to be explained.

show abstract

Personality styles and adherence to treatment in adult patients with Multiple Sclerosis

Cited by 2 publications

References 10 publications

Relationship of personality traits with stigmatization, depression, and quality of life in patients with multiple sclerosis

Relationship of personality traits with stigmatization, depression, and quality of life in patients with multiple sclerosis

Multipl Skleroz Hastalarında Hastalık Modifiye Edici Tedavilere Uyumu Etkileyen Faktörlerin Değerlendirilmesi

Contact Info

Product

Resources

About